ABSTRACT
Additive effect on clotting cascade Watch for bleeding complications. Risk-benefit analysis is needed before co-administering; this will involve availability of alternative therapies such as primary angioplasty
THROMBOLYTICS
THROMBOLYTICS ANTICOAGULANTS – PARENTERAL
THROMBOLYTICS HEPARINS Heparin requirements are ≠ when administered after streptokinase
Uncertain at present Monitor APTT closely when starting heparin after streptokinase.
